Kailera's own 'triple-G' drug also looks very powerful

The business of living forever, Chan Zuckerberg Biohub’s AI protein model, and other biotech news from The Readout

Adobe

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Good morning. Today, we have some AI drug development news and an examination of the growing longevity industry.